Connection

Tali-Anne Szwebel to Immunotherapy

Back to Details
This is a "connection" page, showing publications Tali-Anne Szwebel has written about Immunotherapy.
Tali-Anne Szwebel
Connection Strength
0.064
Immunotherapy
  1. Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis. Eur J Cancer. 2017 09; 82:34-44.
    View in: PubMed
    Score: 0.064
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.